GlassScriptPhysician profile
Theodore Haskin
NPI 1700230554
$272.01
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $30.42 · 2021: $51.34 · 2022: $98.60 · 2023: $91.65.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $91.65.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $91.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $33.42 | 2023 | Ozempic, Rybelsus, Wegovy |
| Si-Bone, INC. | $30.42 | 2020 | |
| Exact Sciences Corporation | $27.97 | 2023 | Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals LP | $23.29 | 2021 | |
| Tactile Systems Technology INC | $20.94 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.93 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.03 | 2022 | |
| Abbvie INC. | $17.22 | 2021 | |
| Merck Sharp & Dohme LLC | $15.88 | 2023 | Belsomra, Verquvo |
| Biohaven Pharmaceutical Holding Company LTD. | $15.62 | 2022 | |
| Pfizer INC. | $14.38 | 2023 | |
| Sanofi-Aventis U.S. LLC | $12.23 | 2022 | |
| Lilly USA, LLC | $11.85 | 2022 | |
| Dynavax Technologies Corporation | $10.83 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Theodore Haskin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.